Mylan Loses Bid to Dismiss Lawsuit A U.S. district judge has ruled that a class action lawsuit against Mylan Inc.,… Read more »
Tag: dbv
FDA Turns Down Viaskin Peanut Patch Approval Bid
The FDA says it won’t approve DBV Technologies’ Viaskin Peanut, the novel skin patch allergy desensitization treatment, at least not… Read more »
DBV Cuts Costs Awaiting FDA; Unveils More Peanut Patch Results
With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
Peanut Patch Therapy Led to Big Quality of Life Improvement for Families
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
Viaskin Peanut Patch Submitted to FDA for Approval Consideration
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »